Matinas BioPharma Holdings, Inc.
MTNB
$0.75
-$0.06-7.19%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -14.15% | -1.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.15% | -5.60% | |||
| Operating Income | 14.15% | 5.60% | |||
| Income Before Tax | 70.79% | -216.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 70.79% | -216.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 70.79% | -216.73% | |||
| EBIT | 14.15% | 5.60% | |||
| EBITDA | 13.54% | 5.35% | |||
| EPS Basic | 61.64% | -216.77% | |||
| Normalized Basic EPS | 24.55% | 2.59% | |||
| EPS Diluted | 61.64% | -216.77% | |||
| Normalized Diluted EPS | 24.55% | 2.59% | |||
| Average Basic Shares Outstanding | 6.86% | 0.00% | |||
| Average Diluted Shares Outstanding | 6.86% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||